(LUCINDA Trial) LeUprolide plus Cholinesterase Inhibition to Reduce Neurological Decline in Alzheimer’s

The PI of this project was:

This project was funded by: NIH

The term of this project was: February 2023 to April 2023

The number of subjects scanned during this project was: 50

This is a research study to determine if the medication Leuprolide can slow or prevent decline in thinking abilities and functioning in women with Alzheimer’s disease (AD) or MCI due to AD who are also taking the medication donepezil (Aricept.) Each subject will undergo a single PET/CT scan as well as two MRI scans.